Insiders · Profile

FOUSE JACQUALYN A

Director at AGIOS PHARMACEUTICALS. Filing since 13 Nov 2019. CIK 0001405288

Company
Date
Role
Action
Shares
Amount
Of holding
10 Apr 2025
Director
Sold on a plan
7,497
$194.17K
4.8%
10 Apr 2024
Director
Sold on a plan
7,791
$214.64K
5.4%
24 Jan 2024
Director
Sold on a plan
10,722
$232.02K
7.7%
9 Jan 2024
Director
Sold on a plan
8,391
$192.91K
6.7%
30 Jun 2023
Director
Sold on a plan
10,718
$303.96K
9.1%
13 Nov 2019
Chief Executive Officer
Bought
40,322
$1.25M
×29
6 decisions on file.